The Effect of Aerobic Exercise on the Irisin/Klotho/Sirtuin-1/BDNF Axis
1 other identifier
interventional
26
1 country
1
Brief Summary
The purpose of this study is to investigate the effects of an acute aerobic exercise on irisin, klotho, sirtuin-1, and BDNF levels in the healthy adults. The findings will help understand the physiological impacts of exercise on these biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedStudy Start
First participant enrolled
September 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 2, 2027
September 2, 2026
August 1, 2026
7 months
August 28, 2026
August 28, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Salivary Irisin Level
Irisin concentration will be determined from a saliva sample using the ELISA technique.
Baseline- immediately after exercise and 1 hours after exercise
Salivary Klotho Level
Klotho concentration will be determined from a saliva sample using the ELISA technique.
Baseline- immediately after exercise and 1 hours after exercise
Salivary Sirtuin Level
Sirtuin concentration will be determined from a saliva sample using the ELISA technique.
Baseline- immediately after exercise and 1 hours after exercise
Salivary BDNF Level
BDNF concentration will be determined from a saliva sample using the ELISA technique.
Baseline- immediately after exercise and 1 hours after exercise
Secondary Outcomes (1)
Saliva Flow Rate
Baseline- İmmediately after exercise and 1 hour after exercise
Study Arms (2)
Experimental Group
EXPERIMENTALAerobic exercise
Control Group
NO INTERVENTIONNo exercise
Interventions
Eligibility Criteria
You may qualify if:
- Being between the ages of 18 and 45
- Being in good health and having no diagnosis of any chronic disease
- Not having taken regular medication within the last 4 weeks
- Voluntary participation and providing written informed consent
You may not qualify if:
- Individuals with a history of cardiovascular, endocrine, metabolic, or renal disease
- Individuals with a history of active infection, musculoskeletal injury, or severe disability
- Individuals with any medical condition that might prevent participation in exercise
- Individuals unable to regularly participate in the exercise protocol throughout the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep University Faculty of Sports Sciences
Gaziantep, Sehitkamil, 85142, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
August 28, 2026
First Posted
September 2, 2026
Study Start
September 2, 2026
Primary Completion (Estimated)
April 2, 2027
Study Completion (Estimated)
May 2, 2027
Last Updated
September 2, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share